Consistent with data in the literature13,42, prolonged treatment with AXL inhibitors led to the partial restoration of epithelial morphology in mesenchymal breast cancer cells (not shown), repression of ZEB1 and reactivation of E-cadherin expression (Fig. 4b). The gene discussed is AXL; the disease is breast cancer.